Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Non-Current Deffered Revenue (2022 - 2023)

Envoy Medical's Non-Current Deffered Revenue history spans 2 years, with the latest figure at $10.4 million for Q2 2023.

  • Quarterly results put Non-Current Deffered Revenue at $10.4 million for Q2 2023, down 30.0% from a year ago — trailing twelve months through Jun 2023 was $10.4 million (down 30.0% YoY), and the annual figure for FY2022 was $10.4 million, changed.
  • Non-Current Deffered Revenue for Q2 2023 was $10.4 million at Envoy Medical, roughly flat from $10.4 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $14.9 million in Q1 2022 to a low of $10.4 million in Q3 2022.